# Structure, Dynamics, and Allosteric Potential of Ionotropic Glutamate Receptor N-Terminal Domains

**Authors:** James Krieger, Ivet Bahar, Ingo H. Greger

PMC · DOI: 10.1016/j.bpj.2015.06.061 · 2015-08-06

## TL;DR

This paper explores the structure and function of the N-terminal domain in ionotropic glutamate receptors, focusing on its role in allosteric regulation and potential for drug development.

## Contribution

The study provides new insights into the allosteric potential of the N-terminal domain in AMPA-type and NMDA-type ionotropic glutamate receptors using coarse-grained simulations.

## Key findings

- The N-terminal domain's clamshell motions are coupled to rearrangements affecting the ligand-binding and transmembrane domains.
- Allosteric regulation in the N-terminal domain impacts receptor function in synaptic environments.
- The bilobate fold of the N-terminal domain is intrinsically linked to allostery in ionotropic glutamate receptors.

## Abstract

Ionotropic glutamate receptors (iGluRs) are tetrameric cation channels that mediate synaptic transmission and plasticity. They have a unique modular architecture with four domains: the intracellular C-terminal domain (CTD) that is involved in synaptic targeting, the transmembrane domain (TMD) that forms the ion channel, the membrane-proximal ligand-binding domain (LBD) that binds agonists such as L-glutamate, and the distal N-terminal domain (NTD), whose function is the least clear. The extracellular portion, comprised of the LBD and NTD, is loosely arranged, mediating complex allosteric regulation and providing a rich target for drug development. Here, we briefly review recent work on iGluR NTD structure and dynamics, and further explore the allosteric potential for the NTD in AMPA-type iGluRs using coarse-grained simulations. We also investigate mechanisms underlying the established NTD allostery in NMDA-type iGluRs, as well as the fold-related metabotropic glutamate and GABAB receptors. We show that the clamshell motions intrinsically favored by the NTD bilobate fold are coupled to dimeric and higher-order rearrangements that impact the iGluR LBD and ultimately the TMD. Finally, we explore the dynamics of intact iGluRs and describe how it might affect receptor operation in a synaptic environment.

## Full-text entities

- **Genes:** GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) [NCBI Gene 2902] {aka DEE101, GluN1, MRD8, NDHMSD, NDHMSR, NMD-R1}, MED1 (mediator complex subunit 1) [NCBI Gene 5469] {aka CRSP1, CRSP200, DRIP205, DRIP230, PBP, PPARBP}, FUZ (fuzzy planar cell polarity protein) [NCBI Gene 80199] {aka CPLANE3, FY, NTD}, CACNG2 (calcium voltage-gated channel auxiliary subunit gamma 2) [NCBI Gene 10369] {aka MRD10}, GLUD1 (glutamate dehydrogenase 1) [NCBI Gene 2746] {aka GDH, GDH1, GLUD, hGDH1}, GLUD2 (glutamate dehydrogenase 2) [NCBI Gene 2747] {aka GDH2, GLUDP1}, GABBR2 (gamma-aminobutyric acid type B receptor subunit 2) [NCBI Gene 9568] {aka DEE59, EIEE59, GABABR2, GPR51, GPRC3B, HG20}, GRIA3 (glutamate ionotropic receptor AMPA type subunit 3) [NCBI Gene 2892] {aka GLUR-C, GLUR-K3, GLUR3, GLURC, GluA3, MRX94}, GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) [NCBI Gene 2904] {aka DEE27, EIEE27, GluN2B, MRD6, NMDAR2B, NR2B}, GRM1 (glutamate metabotropic receptor 1) [NCBI Gene 2911] {aka GPRC1A, MGLU1, MGLUR1, PPP1R85, SCA44, SCAR13}, KAR [NCBI Gene 8083], GRIK3 (glutamate ionotropic receptor kainate type subunit 3) [NCBI Gene 2899] {aka EAA5, GLR7, GLUR7, GluK3, GluR7a}, GRIK5 (glutamate ionotropic receptor kainate type subunit 5) [NCBI Gene 2901] {aka EAA2, GRIK2, GluK5, KA2}, GRIK2 (glutamate ionotropic receptor kainate type subunit 2) [NCBI Gene 2898] {aka EAA4, GLR6, GLUK6, GLUR6, GluK2, MRT6}, GABBR1 (gamma-aminobutyric acid type B receptor subunit 1) [NCBI Gene 2550] {aka GABABR1, GABBR1-3, GB1, GPRC3A, NEDLC}, GRIA2 (glutamate ionotropic receptor AMPA type subunit 2) [NCBI Gene 2891] {aka GLUR2, GLURB, GluA2, GluR-K2, HBGR2, NEDLIB}, NPR1 (natriuretic peptide receptor 1) [NCBI Gene 4881] {aka ANP-A, ANPRA, ANPa, GC-A, GUC2A, GUCY2A}, NPR3 (natriuretic peptide receptor 3) [NCBI Gene 4883] {aka ANP-C, ANPR-C, ANPRC, BOMOS, C5orf23, GUCY2B}, CDH2 (cadherin 2) [NCBI Gene 1000] {aka ACOGS, ADHD8, ARVD14, CD325, CDHN, CDw325}
- **Diseases:** NMDAR (MESH:D060426)
- **Chemicals:** sodium (MESH:D012964), Ifenprodil (MESH:C010739), cyclic peptide (MESH:D010456), hydrogen (MESH:D006859), water (MESH:D014867), TIP3P (-), Glu (MESH:D018698), chloride (MESH:D002712), polyamine (MESH:D011073), GABA (MESH:D005680), spermine (MESH:D013096), natriuretic peptide (MESH:D045265), zinc (MESH:D015032)
- **Cell lines:** S2 C — Canis lupus familiaris (Dog), Canine mastocytoma, Cancer cell line (CVCL_1R44), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4576161/full.md

---
Source: https://tomesphere.com/paper/PMC4576161